Artivion (Artivion) Cash And Cash Equivalents : $58.9 Mil (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Artivion Cash And Cash Equivalents?

Artivion's quarterly cash and cash equivalents increased from Jun. 2023 ($48.78 Mil) to Sep. 2023 ($53.48 Mil) and increased from Sep. 2023 ($53.48 Mil) to Dec. 2023 ($58.94 Mil).

Artivion's annual cash and cash equivalents declined from Dec. 2021 ($55.01 Mil) to Dec. 2022 ($39.35 Mil) but then increased from Dec. 2022 ($39.35 Mil) to Dec. 2023 ($58.94 Mil).

Artivion Cash And Cash Equivalents Historical Data

The historical data trend for Artivion's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artivion Cash And Cash Equivalents Chart

Artivion Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

33.77

61.41

55.01

39.35

58.94

Artivion Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															39.35	30.77	48.78	53.48	58.94

Artivion Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Artivion (NYSE:AORT) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Artivion Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Artivion's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Artivion (Artivion) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Artivion Inc (NYSE:AORT) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

CYL:Germany

Address

1655 Roberts Boulevard North West, Kennesaw, GA, USA, 30144

Website

https://www.artivion.com

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.

Executives

Jean F Holloway	officer: VP, General Counsel	C/O ARTIVION INC, 1655 ROBERTS BLVD, KENNESAW GA 30144
John E Davis	officer: Senior VP, Global Sales	1655 ROBERTS BLVD., NW, KENNESAW GA 30144
Amy Horton	officer: Chief Accounting Officer	C/O CRYOLIFE, INC., 1655 ROBERTS BLVD., NW, KENNESAW GA 30144
Florian Tyrs	officer: VP, Global Operations	IM SOELLER 3, BALINGEN 2M 72336
Robert C Thomson	officer: VP Research & Development	33 HABERSHAM COVE DRIVE, NW, ATLANTA GA 30305
Matthew A Getz	officer: VP, Human Resources	1655 ROBERTS BLVD NW, KENNESAW GA 30144
Dennis B Maier	officer: Vice President, Operations	1655 ROBERTS BLVD, NW, KENNESAW GA 30144
Rochelle L. Maney	officer: VP, Quality	1655 ROBERTS BLVD, NW, KENNESAW GA 30144
James P Mackin	officer: President & CEO	ARTIVION, INC., 1655 ROBERTS BLVD, NW, KENNESAW GA 30144
Marshall S. Stanton	officer: SVP, Clinical & MD Affair	1655 ROBERTS BLVD, NW, KENNESAW GA 30144
Andrew M Green	officer: VP Regulatory	ARTIVION INC, 1655 ROBERTS BLVD, KENNESAW GA 30144
David Ashley Lee	officer: Executive VP, COO & CFO	C/O CRYOLIFE INC, 1655 ROBERTS BLVD NW, KENNESAW GA 30144
Elizabeth A Hoff	director	2701 WESTHEIMER ROAD, UNIT 1-E, HOUSTON TX 77098
Anthony B. Semedo	director	3288 HARRISON GRADE ROAD, SEBASTOPOL CA 95472
Ronald D Mccall	director	C/O CRYOLIFE, INC., 1655 ROBERTS BOULEVARD, NW, KENNESAW GA 30144